Clinical treatment of polycystic kidney disease (APKD): Do we need further suggestions from rodents?

Nephrology Dialysis Transplantation

Volumn 26, Issue 6, 2011, Pages 2065-2066

  Sabbatini, Massimo ^a   Russo, Luigi ^a   Uccello, Francesco ^b   Iaccarino, Antonino ^b   Pisani, Antonio ^a  

^a Department of Systematic Pathology ^*  (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; EVEROLIMUS; RAPAMYCIN; S6 KINASE;

BILIRUBIN BLOOD LEVEL; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; EXPERIMENTAL RAT; GLOMERULUS FILTRATION RATE; HYPERBILIRUBINEMIA; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY POLYCYSTIC DISEASE; LETTER; LIVER FUNCTION; LIVER TOXICITY; LOW DRUG DOSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT DURATION; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; POLYCYSTIC KIDNEY DISEASES;

EID: 79958135427     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr117     Document Type: Letter

References (5)

1. Chilcot J, Davenport A, Wellsted D et al. An association between depressive symptoms and survival in incident dialysis patients. Nephrol Dial Transplant 2011; 26: 1628-1634.
2. Balogun RA, Turgut F, Balogun SA et al. Screening for depression in elderly hemodialysis patients. Nephron Clin Pract 2010; 118: c72-c77.
3. Diefenthaeler EC, Wagner MB, Poli-de-Figueiredo CE et al. Is depression a risk factor for mortality in chronic hemodialysis patients? Rev Bras Psiquiatr 2008; 30: 99-103. (Pubitemid 351958409)
4. Connerney I, Sloan RP, Shapiro PA et al. Depression is associated with increased mortality 10 years after coronary artery bypass surgery. Psychosom Med 2010; 72: 874-881.
5. Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychol Med 2010; 40: 1797-1810